News Focus
News Focus
icon url

rule_rationale

06/22/20 10:49 PM

#304576 RE: KMBJN #304574

The Shield of Life and The Guardian of The Genome, both owned by IPIX, a publicly traded company, far out!
icon url

PlentyParanoid

06/22/20 11:24 PM

#304588 RE: KMBJN #304574

Speaking about "The Guardian of Genome". Aprea should be close of announcing top line results for their ARP-246 in treatment of TP53-mutated MDS. Some are expecting news as early as this month. Official primary completion date is still in November 2020.

If the trial is successful news might give IPIX a boost... or not. With IPIX you never know.
icon url

thefamilyman

06/23/20 1:56 PM

#304837 RE: KMBJN #304574

You said, “Great interview. I will now think of brilacidin as ‘the shield of life’ to match ‘the guardian of the genome’.”

I like it!